{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:10:32Z","timestamp":1780708232908,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Bethune Foundation Research Program for Young and Middle-aged Thyroid Doctors","award":["JKM2022-B06"],"award-info":[{"award-number":["JKM2022-B06"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 82160462"],"award-info":[{"award-number":["Grant No. 82160462"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Yunnan Provincial Science and Technology Department","award":["Grant No. 202301AY070001-047"],"award-info":[{"award-number":["Grant No. 202301AY070001-047"]}]},{"name":"the Yunnan Academician and Expert Workstation","award":["No. 202205AF150023"],"award-info":[{"award-number":["No. 202205AF150023"]}]},{"name":"the Yunnan Fundamental Research Projects","award":["Grant No. 202201AS070068"],"award-info":[{"award-number":["Grant No. 202201AS070068"]}]},{"name":"the Xingdian Talents Support Program","award":["Grant No. RLMY20220012"],"award-info":[{"award-number":["Grant No. RLMY20220012"]}]},{"name":"the 535 Talent Project of the First Affiliated Hospital of Kunming Medical University","award":["Grant No. 2023535D07"],"award-info":[{"award-number":["Grant No. 2023535D07"]}]},{"name":"the Yunnan Clinical Medical Center for Endocrine and Metabolic Disease","award":["No. YWLCYXZXXYS20221005"],"award-info":[{"award-number":["No. YWLCYXZXXYS20221005"]}]},{"name":"\u201cTen thousand Talents Plan\u201d of Yunnan Province-Special Fund for famous doctors","award":["RLCRC20211206"],"award-info":[{"award-number":["RLCRC20211206"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03864-7","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:20:44Z","timestamp":1762255244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inflammation related proteins and PLCG1 may contribute to papillary thyroid carcinoma risk through a potential regulatory axis"],"prefix":"10.1007","volume":"16","author":[{"given":"Shi-Qi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Wei","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-Chuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"10387","key":"3864_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet. 2023;401(10387):1531\u201344.","journal-title":"Lancet"},{"issue":"3","key":"3864_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3864_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ecl.2018.10.002","volume":"48","author":"CD Seib","year":"2019","unstructured":"Seib CD, Sosa JA. Evolving Understanding of the epidemiology of thyroid cancer. Endocrinol Metab Clin North Am. 2019;48(1):23\u201335.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"3864_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ecl.2014.02.011","volume":"43","author":"GG Callender","year":"2014","unstructured":"Callender GG, Carling T, Christison-Lagay E, Udelsman R. Surgery for thyroid cancer. Endocrinol Metab Clin North Am. 2014;43(2):443\u201358.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"11","key":"3864_CR5","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1089\/thy.2014.0173","volume":"24","author":"LY Wang","year":"2014","unstructured":"Wang LY, Palmer FL, Nixon IJ, Thomas D, Patel SG, Shaha AR, et al. Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer. Thyroid. 2014;24(11):1594\u20139.","journal-title":"Thyroid"},{"issue":"5","key":"3864_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4158\/EP-2018-0465","volume":"25","author":"O Slook","year":"2019","unstructured":"Slook O, Levy S, Slutzky-Shraga I, Tsvetov G, Robenshtok E, Shimon I, et al. Long-term outcomes and prognostic factors in patients with differentiated thyroid carcinoma and bone metastases. Endocr Pract. 2019;25(5):427\u201337.","journal-title":"Endocr Pract"},{"issue":"6","key":"3864_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.clon.2010.03.014","volume":"22","author":"SI Sherman","year":"2010","unstructured":"Sherman SI. Cytotoxic chemotherapy for differentiated thyroid carcinoma. Clin Oncol (R Coll Radiol). 2010;22(6):464\u20138.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"9940","key":"3864_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","volume":"384","author":"MS Brose","year":"2014","unstructured":"Brose MS, Nutting CM, Jarzab B, Elisei R, Siena S, Bastholt L, et al. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet. 2014;384(9940):319\u201328.","journal-title":"Lancet"},{"issue":"15suppl","key":"3864_CR9","doi-asserted-by":"publisher","first-page":"LBA6008","DOI":"10.1200\/jco.2014.32.18_suppl.lba6008","volume":"32","author":"M Schlumberger","year":"2014","unstructured":"Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, et al. A phase 3, multicenter, double-blind, placebo-controlled trial of lenvatinib (E7080) in patients with 131I-refractory differentiated thyroid cancer (SELECT). JCO. 2014;32(15suppl):LBA6008\u20136008.","journal-title":"JCO"},{"key":"3864_CR10","first-page":"281","volume":"8","author":"S Jasim","year":"2014","unstructured":"Jasim S, Ozsari L, Habra MA. Multikinase inhibitors use in differentiated thyroid carcinoma. Biologics. 2014;8:281\u201391.","journal-title":"Biologics"},{"issue":"2","key":"3864_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4103\/jcrt.jcrt_1471_22","volume":"19","author":"M Boruah","year":"2023","unstructured":"Boruah M, Gaddam P, Agarwal S, Mir RA, Gupta R, Sharma MC, et al. PD-L1 expression in rare and aggressive thyroid cancers: A preliminary investigation for a role of immunotherapy. J Cancer Res Ther. 2023;19(2):312\u201320.","journal-title":"J Cancer Res Ther"},{"issue":"8","key":"3864_CR12","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1080\/08820139.2023.2268656","volume":"52","author":"Y Tao","year":"2023","unstructured":"Tao Y, Li P, Feng C, Cao Y. New insights into immune cells and immunotherapy for thyroid cancer. Immunol Invest. 2023;52(8):1039\u201364.","journal-title":"Immunol Invest"},{"key":"3864_CR13","doi-asserted-by":"publisher","first-page":"101013","DOI":"10.1016\/j.drup.2023.101013","volume":"72","author":"H Shen","year":"2024","unstructured":"Shen H, Zhu R, Liu Y, Hong Y, Ge J, Xuan J, et al. Radioiodine-refractory differentiated thyroid cancer: molecular mechanisms and therapeutic strategies for radioiodine resistance. Drug Resist Updat. 2024;72:101013.","journal-title":"Drug Resist Updat"},{"issue":"8","key":"3864_CR14","doi-asserted-by":"publisher","first-page":"e492","DOI":"10.1002\/ctm2.492","volume":"11","author":"T Du","year":"2021","unstructured":"Du T, Gao J, Li P, Wang Y, Qi Q, Liu X, et al. Pyroptosis, metabolism, and tumor immune microenvironment. Clin Transl Med. 2021;11(8):e492.","journal-title":"Clin Transl Med"},{"issue":"5","key":"3864_CR15","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/biom13050820","volume":"13","author":"P Zhou","year":"2023","unstructured":"Zhou P, Zhang S, Wang M, Zhou J. The induction mechanism of Ferroptosis, Necroptosis, and pyroptosis in inflammatory bowel Disease, colorectal Cancer, and intestinal injury. Biomolecules. 2023;13(5):820.","journal-title":"Biomolecules"},{"key":"3864_CR16","doi-asserted-by":"publisher","first-page":"1282710","DOI":"10.3389\/fimmu.2023.1282710","volume":"14","author":"KS Lui","year":"2023","unstructured":"Lui KS, Ye Z, Chan HC, Tanaka Y, Cheung AKL. Anti-PD1 does not improve pyroptosis induced by \u03b3\u03b4 T cells but promotes tumor regression in a pleural mesothelioma mouse model. Front Immunol. 2023;14:1282710.","journal-title":"Front Immunol"},{"key":"3864_CR17","doi-asserted-by":"publisher","first-page":"121498","DOI":"10.1016\/j.lfs.2023.121498","volume":"318","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang C, Lin C. Pyroptosis as a double-edged sword: the pathogenic and therapeutic roles in inflammatory diseases and cancers. Life Sci. 2023;318:121498.","journal-title":"Life Sci"},{"issue":"1","key":"3864_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.chom.2018.05.009","volume":"24","author":"R Kang","year":"2018","unstructured":"Kang R, Zeng L, Zhu S, Xie Y, Liu J, Wen Q, et al. Lipid peroxidation drives gasdermin D-Mediated pyroptosis in lethal polymicrobial sepsis. Cell Host Microbe. 2018;24(1):97\u2013e1084.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"3864_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jid.2019.07.693","volume":"140","author":"VM Patel","year":"2020","unstructured":"Patel VM, Flanagan CE, Martins M, Jones CL, Butler RM, Woollard WJ, et al. Frequent and persistent PLCG1 mutations in S\u00e9zary cells directly enhance PLC\u03b31 activity and stimulate NF\u03baB, AP-1, and NFAT signaling. J Invest Dermatol. 2020;140(2):380\u2013e3894.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"3864_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.chom.2018.05.009","volume":"24","author":"R Kang","year":"2018","unstructured":"Kang R, Zeng L, Zhu S, et al. Lipid peroxidation drives gasdermin D-mediated pyroptosis in lethal polymicrobial sepsis. Cell Host Microbe. 2018;24(1):97\u2013e1084.","journal-title":"Cell Host Microbe"},{"issue":"28","key":"3864_CR21","doi-asserted-by":"publisher","first-page":"11282","DOI":"10.1073\/pnas.1117765109","volume":"109","author":"T Murakami","year":"2012","unstructured":"Murakami T, Ockinger J, Yu J, et al. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proc Natl Acad Sci U S A. 2012;109(28):11282\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3864_CR22","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.jaci.2023.06.020","volume":"152","author":"P Tao","year":"2023","unstructured":"Tao P, Han X, Wang Q, Wang S, Zhang J, Liu L, et al. A gain-of-function variation in PLCG1 causes a new immune dysregulation disease. J Allergy Clin Immunol. 2023;152(5):1292\u2013302.","journal-title":"J Allergy Clin Immunol"},{"issue":"13","key":"3864_CR23","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1182\/blood-2013-05-504308","volume":"123","author":"JP Vaqu\u00e9","year":"2014","unstructured":"Vaqu\u00e9 JP, G\u00f3mez-L\u00f3pez G, Mons\u00e1lvez V, Varela I, Mart\u00ednez N, P\u00e9rez C, et al. PLCG1 mutations in cutaneous T-cell lymphomas. Blood. 2014;123(13):2034\u201343.","journal-title":"Blood"},{"issue":"1","key":"3864_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12943-024-02217-2","volume":"24","author":"P Zhao","year":"2025","unstructured":"Zhao P, Yin S, Qiu Y, Sun C, Yu H. Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance. Mol Cancer. 2025;24(1):23.","journal-title":"Mol Cancer"},{"issue":"1","key":"3864_CR25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13287-025-04167-y","volume":"16","author":"H Li","year":"2025","unstructured":"Li H, Zhang P, Lin M, Li K, Zhang C, He X, et al. Pyroptosis: candidate key targets for mesenchymal stem cell-derived exosomes for the treatment of bone-related diseases. Stem Cell Res Ther. 2025;16(1):68.","journal-title":"Stem Cell Res Ther"},{"issue":"W1","key":"3864_CR26","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkab418","volume":"49","author":"C Li","year":"2021","unstructured":"Li C, Tang Z, Zhang W, Ye Z, Liu F. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021;49(W1):W242\u20136.","journal-title":"Nucleic Acids Res"},{"key":"3864_CR27","doi-asserted-by":"publisher","first-page":"702638","DOI":"10.3389\/fmed.2021.702638","volume":"8","author":"D Xu","year":"2021","unstructured":"Xu D, Ji Z, Qiang L, Molecular, Characteristics. Clinical Implication, and cancer immunity interactions of Pyroptosis-Related genes in breast cancer. Front Med (Lausanne). 2021;8:702638.","journal-title":"Front Med (Lausanne)"},{"issue":"1 Pt 3","key":"3864_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.gene.2015.10.060","volume":"576","author":"Z Yang","year":"2016","unstructured":"Yang Z, Zhuan B, Yan Y, Jiang S, Wang T. Identification of gene markers in the development of smoking-induced lung cancer. Gene. 2016;576(1 Pt 3):451\u20137.","journal-title":"Gene"},{"issue":"11","key":"3864_CR29","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1158\/1541-7786.MCR-20-0075","volume":"18","author":"W Song","year":"2020","unstructured":"Song W, Kim LC, Han W, Hou Y, Edwards DN, Wang S, et al. Phosphorylation of PLC\u03b31 by EphA2 receptor tyrosine kinase promotes tumor growth in lung cancer. Mol Cancer Res. 2020;18(11):1735\u201343.","journal-title":"Mol Cancer Res"},{"issue":"22","key":"3864_CR30","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1158\/0008-5472.CAN-20-1453","volume":"80","author":"KB Kim","year":"2020","unstructured":"Kim KB, Kim Y, Rivard CJ, Kim DW, Park KS. FGFR1 is critical for RBL2 Loss-Driven tumor development and requires PLCG1 activation for continued growth of small cell lung cancer. Cancer Res. 2020;80(22):5051\u201362.","journal-title":"Cancer Res"},{"issue":"2","key":"3864_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41374-021-00682-7","volume":"102","author":"T Li","year":"2022","unstructured":"Li T, Yang Z, Li H, Zhu J, Wang Y, Tang Q, et al. Phospholipase C\u03b31 (PLCG1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients. Lab Invest. 2022;102(2):143\u201353.","journal-title":"Lab Invest"},{"issue":"11","key":"3864_CR32","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.3390\/ijms23116178","volume":"23","author":"W Xie","year":"2022","unstructured":"Xie W, Li X, Yang C, Li J, Shen G, Chen H, et al. The Pyroptosis-Related gene prognostic index associated with tumor immune infiltration for pancreatic cancer. Int J Mol Sci. 2022;23(11):6178.","journal-title":"Int J Mol Sci"},{"key":"3864_CR33","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.12659\/MSM.909205","volume":"24","author":"D Zhou","year":"2018","unstructured":"Zhou D, Li Z, Bai X. BRAF V600E and RET\/PTC promote the activity of nuclear factor-\u03baB, inflammatory mediators, and lymph node metastasis in papillary thyroid carcinoma: a study of 50 patients in inner Mongolia. Med Sci Monit. 2018;24:6795\u2013808.","journal-title":"Med Sci Monit"},{"key":"3864_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41389-023-00496-w","volume":"12","author":"F Cormier","year":"2023","unstructured":"Cormier F, Housni S, Dumont F, et al. NF-\u03baB signaling activation and roles in thyroid cancers: implication of MAP3K14\/NIK. Oncogenesis. 2023;12:55.","journal-title":"Oncogenesis"},{"issue":"10","key":"3864_CR35","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.autrev.2020.102649","volume":"19","author":"M Ralli","year":"2020","unstructured":"Ralli M, Angeletti D, Fiore M, et al. Hashimoto\u2019s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020;19(10):102649.","journal-title":"Autoimmun Rev"},{"key":"3864_CR36","doi-asserted-by":"publisher","first-page":"1551271","DOI":"10.3389\/fendo.2025.1551271","volume":"16","author":"X Xue","year":"2025","unstructured":"Xue X, Wu D, Yao H, Wang K, Liu Z, Qu H. Mechanisms underlying the promotion of papillary thyroid carcinoma occurrence and progression by hashimoto\u2019s thyroiditis. Front Endocrinol (Lausanne). 2025;16:1551271.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3864_CR37","doi-asserted-by":"publisher","first-page":"801925","DOI":"10.3389\/fendo.2022.801925","volume":"13","author":"J Xu","year":"2022","unstructured":"Xu J, Ding K, Mu L, et al. Hashimoto\u2019s thyroiditis: a double-edged sword in thyroid carcinoma. Front Endocrinol (Lausanne). 2022;13:801925.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"3864_CR38","doi-asserted-by":"publisher","first-page":"e2118526","DOI":"10.1001\/jamanetworkopen.2021.18526","volume":"4","author":"S Xu","year":"2021","unstructured":"Xu S, Huang H, Qian J, et al. Prevalence of Hashimoto thyroiditis in adults with papillary thyroid cancer and its association with cancer recurrence and outcomes. JAMA Netw Open. 2021;4(7):e2118526.","journal-title":"JAMA Netw Open"},{"key":"3864_CR39","doi-asserted-by":"publisher","first-page":"5443244","DOI":"10.1155\/ijog\/5443244","volume":"2025","author":"D Zhu","year":"2025","unstructured":"Zhu D, Cao L. SMPD3 as a potential biomarker and therapeutic target in hepatocellular carcinoma. Int J Genomics. 2025;2025:5443244.","journal-title":"Int J Genomics"},{"issue":"6","key":"3864_CR40","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1053\/j.gastro.2013.08.055","volume":"145","author":"K Revill","year":"2013","unstructured":"Revill K, Wang T, Lachenmayer A, Kojima K, Harrington A, Li J, et al. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma. Gastroenterology. 2013;145(6):1424\u201335. e1-25.","journal-title":"Gastroenterology"},{"issue":"2","key":"3864_CR41","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","volume":"177","author":"M Poggio","year":"2019","unstructured":"Poggio M, Hu T, Pai CC, Chu B, Belair CD, Chang A, et al. Suppression of Exosomal PD-L1 induces systemic Anti-tumor immunity and memory. Cell. 2019;177(2):414\u2013e42713.","journal-title":"Cell"},{"issue":"5","key":"3864_CR42","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1158\/2326-6066.CIR-20-0342","volume":"9","author":"A Montfort","year":"2021","unstructured":"Montfort A, Bertrand F, Rochotte J, Gilhodes J, Filleron T, Milh\u00e8s J, et al. Neutral Sphingomyelinase 2 heightens Anti-Melanoma immune responses and Anti-PD-1 therapy efficacy. Cancer Immunol Res. 2021;9(5):568\u201382.","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"3864_CR43","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/sj.emboj.7600978","volume":"25","author":"A Braiman","year":"2006","unstructured":"Braiman A, Barda-Saad M, Sommers CL, Samelson LE. Recruitment and activation of PLCgamma1 in T cells: a new insight into old domains. EMBO J. 2006;25(4):774\u201384.","journal-title":"EMBO J"},{"issue":"1","key":"3864_CR44","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbamem.2008.07.030","volume":"1788","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Li X, Becker KA, Gulbins E. Ceramide-enriched membrane domains\u2013structure and function. Biochim Biophys Acta. 2009;1788(1):178\u201383.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"3864_CR45","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.3892\/ol.2015.3707","volume":"10","author":"J Wang","year":"2015","unstructured":"Wang J, Li J, Gu J, Yu J, Guo S, Zhu Y, et al. Abnormal methylation status of FBXW10 and SMPD3, and associations with clinical characteristics in clear cell renal cell carcinoma. Oncol Lett. 2015;10(5):3073\u201380.","journal-title":"Oncol Lett"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03864-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03864-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03864-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T12:04:27Z","timestamp":1762257867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03864-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3864"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03864-7","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data used in this study were obtained from publicly available databases and previously published studies. Only summary-level genetic and phenotypic data were analyzed, with no access to individual-level or identifiable participant information. Therefore, no additional ethical approval or informed consent was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2033"}}